The other three — Tofidence™ and Tyenne® for Actemra® (tocilizumab) and Pavblu™ for Eylea® (aflibercept) — were the first commercially available biosimilars for their respective ...
The intravenous biosimilar of IL-6 inhibitor Actemra (tocilizumab) – called Tofidence (formerly BIIB800) – has been cleared for three of the indications for which Roche’s drug is used ...
and TOFIDENCE, a tocilizumab biosimilar referencing ACTEMRA. It offers RITUXAN to treat non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, two forms of ANCA-associated ...
and TOFIDENCE, a tocilizumab biosimilar referencing ACTEMRA. It offers RITUXAN to treat non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, two forms of ANCA-associated ...
Inflammatory bowel disease is a diverse disease that affects people all over the globe. This diversity in setting and treatment options makes it difficult for researchers to estimate the exact cost of ...
Environmental factors like diet and early antibiotic use have an impact on the gut microbiome and can contribute to ...
Last month, the United States District Court for the Western District of Texas enjoined parts of the state's Securing Children Online Through Parental Empowerment (SCOPE) Act, a law requiring ...
After hours: March 13 at 7:37:36 PM EDT Loading Chart for BIIB ...
Pre-market: 4:36:52 am GMT-5 ...
Pre-Market: 5:58:06 a.m. EDT Loading Chart for BIIB ...
Pre-market: 4:10:20 am GMT-5 Loading Chart for BIIB ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback